Podcast

Management of Heart Failure with Normal EF: A Geriatric Disease?

Presented at the 6th Annual Dartmouth Conference on Advances in Heart Failure at the Dartmouth Hitchcock Medical Center, Lebanon, N.H.

Mathew S. Maurer, MD, director, Clinical Cardiovascular Research Laboratory for the Elderly, Columbia University Medical Center, New York, discusses “Management of Heart Failure with Normal EF: A Geriatric Disease?” Presented at the 6th Annual Dartmouth Conference on Advances in Heart Failure, held Monday, May 24, 2010, at the Dartmouth Hitchcock Medical Center, Lebanon, N.H.

Click here to access this third-party resource.

Related Videos
Experts' Perspectives: Top Stories in Cardiology for 2024
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Matthew Weir, MD: Prioritizing Cardiovascular Risk in Chronic Kidney Disease | Image Credit: University of Maryland
Related Content
Credit: Preeti N. Malani, MD I University of Michigan
December 10th 2024

Adults aged 50 – 80 years Often Experience Loneliness, Social isolation

Chelsie Derman
Site Logo
December 23rd 2024

Navigating Lifestyle and Pharmacotherapy Interventions in Dyslipidemia Management

Pam R. Taub, MD, FACC, FASPC Marc P. Bonaca, MD, MPH
Rushad Patell, MD | Credit: BIDMC
December 8th 2024

GLP-1 Receptor Agonists Could Reduce Stroke Risk in Type 2 Diabetes

Patrick Campbell
Video: Exploring Bempedoic Acid: Clinical Indications, Efficacy, and Future Directions in Cardiovascular Risk Management
December 17th 2024

Video: Exploring Bempedoic Acid: Clinical Indications, Efficacy, and Future Directions in Cardiovascular Risk Management

Pam R. Taub, MD, FACC, FASPC Marc P. Bonaca, MD, MPH
Emerson C. Perin, MD, PhD, Medical Director, The Texas Heart Institute
December 5th 2024

Cell Therapy Gets RMAT Designation for HLHS, Improves Survival in Heart Failure With Reduced Ejection Fraction

Victoria Johnson
Anemia Negatively Impacts Right Ventricular Function in Patients with HFpEF | Image Credit: Fotolia
December 3rd 2024

Anemia Negatively Impacts Right Ventricular Function in Patients with HFpEF

Connor Iapoce
© 2024 MJH Life Sciences

All rights reserved.